Go Pro

Canopy Growth (CGC) Competitors

Canopy Growth logo
$0.99 -0.01 (-1.05%)
As of 09:38 AM Eastern
This is a fair market value price provided by Massive. Learn more.

CGC vs. ACB, CRON, OGI, SNDL, and TLRY

Should you buy Canopy Growth stock or one of its competitors? Canopy Growth's main competitors and comparable companies include Aurora Cannabis (ACB), Cronos Group (CRON), Organigram Global (OGI), SNDL (SNDL), and Tilray Brands (TLRY). Companies are selected based on similarities in market, industry, and size.

How does Canopy Growth compare to Aurora Cannabis?

Aurora Cannabis (NASDAQ:ACB) and Canopy Growth (NASDAQ:CGC) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, dividends, media sentiment, risk, valuation, profitability, analyst recommendations and institutional ownership.

In the previous week, Aurora Cannabis had 2 more articles in the media than Canopy Growth. MarketBeat recorded 7 mentions for Aurora Cannabis and 5 mentions for Canopy Growth. Canopy Growth's average media sentiment score of 0.74 beat Aurora Cannabis' score of 0.10 indicating that Canopy Growth is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Aurora Cannabis
0 Very Positive mention(s)
2 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
3 Very Negative mention(s)
Neutral
Canopy Growth
2 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Aurora Cannabis has a beta of 0.58, indicating that its share price is 42% less volatile than the broader market. Comparatively, Canopy Growth has a beta of 0.81, indicating that its share price is 19% less volatile than the broader market.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Aurora Cannabis
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
2.50
Canopy Growth
1 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.20

Aurora Cannabis has higher earnings, but lower revenue than Canopy Growth. Aurora Cannabis is trading at a lower price-to-earnings ratio than Canopy Growth, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aurora Cannabis$247.82M1.05-$88.13M-$1.41N/A
Canopy Growth$251.01M1.79-$190.29M-$0.45N/A

47.6% of Aurora Cannabis shares are owned by institutional investors. Comparatively, 3.3% of Canopy Growth shares are owned by institutional investors. 0.0% of Aurora Cannabis shares are owned by insiders. Comparatively, 0.4% of Canopy Growth shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Aurora Cannabis has a net margin of -32.26% compared to Canopy Growth's net margin of -65.33%. Aurora Cannabis' return on equity of 4.37% beat Canopy Growth's return on equity.

Company Net Margins Return on Equity Return on Assets
Aurora Cannabis-32.26% 4.37% 3.45%
Canopy Growth -65.33%-21.91%-14.34%

Summary

Aurora Cannabis and Canopy Growth tied by winning 8 of the 16 factors compared between the two stocks.

How does Canopy Growth compare to Cronos Group?

Cronos Group (NASDAQ:CRON) and Canopy Growth (NASDAQ:CGC) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, earnings, institutional ownership, media sentiment, valuation, risk, analyst recommendations and dividends.

Cronos Group has a net margin of 39.08% compared to Canopy Growth's net margin of -65.33%. Cronos Group's return on equity of 4.85% beat Canopy Growth's return on equity.

Company Net Margins Return on Equity Return on Assets
Cronos Group39.08% 4.85% 4.62%
Canopy Growth -65.33%-21.91%-14.34%

Cronos Group presently has a consensus target price of $2.30, suggesting a potential downside of 31.95%. Given Cronos Group's stronger consensus rating and higher probable upside, research analysts clearly believe Cronos Group is more favorable than Canopy Growth.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cronos Group
0 Sell rating(s)
2 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.60
Canopy Growth
1 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.20

In the previous week, Cronos Group had 2 more articles in the media than Canopy Growth. MarketBeat recorded 7 mentions for Cronos Group and 5 mentions for Canopy Growth. Cronos Group's average media sentiment score of 1.10 beat Canopy Growth's score of 0.74 indicating that Cronos Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Cronos Group
4 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Canopy Growth
2 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

8.7% of Cronos Group shares are held by institutional investors. Comparatively, 3.3% of Canopy Growth shares are held by institutional investors. 7.8% of Cronos Group shares are held by company insiders. Comparatively, 0.4% of Canopy Growth shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Cronos Group has a beta of 0.9, indicating that its share price is 10% less volatile than the broader market. Comparatively, Canopy Growth has a beta of 0.81, indicating that its share price is 19% less volatile than the broader market.

Cronos Group has higher earnings, but lower revenue than Canopy Growth. Canopy Growth is trading at a lower price-to-earnings ratio than Cronos Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cronos Group$146.59M8.55-$9.45M$0.2016.90
Canopy Growth$251.01M1.79-$190.29M-$0.45N/A

Summary

Cronos Group beats Canopy Growth on 15 of the 16 factors compared between the two stocks.

How does Canopy Growth compare to Organigram Global?

Organigram Global (NASDAQ:OGI) and Canopy Growth (NASDAQ:CGC) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, institutional ownership, risk, earnings, analyst recommendations, dividends, media sentiment and profitability.

Organigram Global has higher earnings, but lower revenue than Canopy Growth. Canopy Growth is trading at a lower price-to-earnings ratio than Organigram Global, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Organigram Global$185.07M0.93-$17.70M$0.462.64
Canopy Growth$251.01M1.79-$190.29M-$0.45N/A

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Organigram Global
1 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.33
Canopy Growth
1 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.20

Organigram Global has a net margin of 28.14% compared to Canopy Growth's net margin of -65.33%. Organigram Global's return on equity of -13.39% beat Canopy Growth's return on equity.

Company Net Margins Return on Equity Return on Assets
Organigram Global28.14% -13.39% -8.67%
Canopy Growth -65.33%-21.91%-14.34%

34.6% of Organigram Global shares are held by institutional investors. Comparatively, 3.3% of Canopy Growth shares are held by institutional investors. 0.1% of Organigram Global shares are held by company insiders. Comparatively, 0.4% of Canopy Growth shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

In the previous week, Canopy Growth had 4 more articles in the media than Organigram Global. MarketBeat recorded 5 mentions for Canopy Growth and 1 mentions for Organigram Global. Organigram Global's average media sentiment score of 1.87 beat Canopy Growth's score of 0.74 indicating that Organigram Global is being referred to more favorably in the media.

Company Overall Sentiment
Organigram Global Very Positive
Canopy Growth Positive

Organigram Global has a beta of 1.46, indicating that its stock price is 46% more volatile than the broader market. Comparatively, Canopy Growth has a beta of 0.81, indicating that its stock price is 19% less volatile than the broader market.

Summary

Organigram Global beats Canopy Growth on 10 of the 14 factors compared between the two stocks.

How does Canopy Growth compare to SNDL?

Canopy Growth (NASDAQ:CGC) and SNDL (NASDAQ:SNDL) are related small-cap companies, but which is the better stock? We will compare the two companies based on the strength of their risk, analyst recommendations, dividends, institutional ownership, earnings, media sentiment, valuation and profitability.

In the previous week, Canopy Growth had 3 more articles in the media than SNDL. MarketBeat recorded 5 mentions for Canopy Growth and 2 mentions for SNDL. SNDL's average media sentiment score of 1.18 beat Canopy Growth's score of 0.74 indicating that SNDL is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Canopy Growth
2 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
SNDL
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

3.3% of Canopy Growth shares are held by institutional investors. 0.4% of Canopy Growth shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

SNDL has higher revenue and earnings than Canopy Growth. SNDL is trading at a lower price-to-earnings ratio than Canopy Growth, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Canopy Growth$251.01M1.79-$190.29M-$0.45N/A
SNDL$677.32M0.51-$11.29M-$0.06N/A

Canopy Growth has a beta of 0.81, indicating that its share price is 19% less volatile than the broader market. Comparatively, SNDL has a beta of 0.93, indicating that its share price is 7% less volatile than the broader market.

SNDL has a net margin of -2.36% compared to Canopy Growth's net margin of -65.33%. SNDL's return on equity of -2.01% beat Canopy Growth's return on equity.

Company Net Margins Return on Equity Return on Assets
Canopy Growth-65.33% -21.91% -14.34%
SNDL -2.36%-2.01%-1.67%

SNDL has a consensus target price of $5.00, indicating a potential upside of 269.00%. Given SNDL's higher probable upside, analysts clearly believe SNDL is more favorable than Canopy Growth.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Canopy Growth
1 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.20
SNDL
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

Summary

SNDL beats Canopy Growth on 9 of the 16 factors compared between the two stocks.

How does Canopy Growth compare to Tilray Brands?

Tilray Brands (NASDAQ:TLRY) and Canopy Growth (NASDAQ:CGC) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, risk, earnings, analyst recommendations, institutional ownership, profitability, valuation and dividends.

Tilray Brands has higher revenue and earnings than Canopy Growth. Tilray Brands is trading at a lower price-to-earnings ratio than Canopy Growth, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Tilray Brands$915.45M0.68-$121.40M-$1.08N/A
Canopy Growth$251.01M1.79-$190.29M-$0.45N/A

9.4% of Tilray Brands shares are owned by institutional investors. Comparatively, 3.3% of Canopy Growth shares are owned by institutional investors. 0.8% of Tilray Brands shares are owned by company insiders. Comparatively, 0.4% of Canopy Growth shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Tilray Brands has a net margin of -13.11% compared to Canopy Growth's net margin of -65.33%. Tilray Brands' return on equity of -7.76% beat Canopy Growth's return on equity.

Company Net Margins Return on Equity Return on Assets
Tilray Brands-13.11% -7.76% -5.59%
Canopy Growth -65.33%-21.91%-14.34%

In the previous week, Tilray Brands had 8 more articles in the media than Canopy Growth. MarketBeat recorded 13 mentions for Tilray Brands and 5 mentions for Canopy Growth. Canopy Growth's average media sentiment score of 0.74 beat Tilray Brands' score of 0.56 indicating that Canopy Growth is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Tilray Brands
3 Very Positive mention(s)
2 Positive mention(s)
7 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Canopy Growth
2 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Tilray Brands presently has a consensus target price of $8.00, suggesting a potential upside of 74.29%. Given Tilray Brands' stronger consensus rating and higher probable upside, research analysts plainly believe Tilray Brands is more favorable than Canopy Growth.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Tilray Brands
1 Sell rating(s)
3 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
2.43
Canopy Growth
1 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.20

Tilray Brands has a beta of 1.9, meaning that its stock price is 90% more volatile than the broader market. Comparatively, Canopy Growth has a beta of 0.81, meaning that its stock price is 19% less volatile than the broader market.

Summary

Tilray Brands beats Canopy Growth on 12 of the 16 factors compared between the two stocks.

Get Canopy Growth News Delivered to You Automatically

Sign up to receive the latest news and ratings for CGC and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CGC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CGC vs. The Competition

MetricCanopy GrowthPharmaceuticals IndustryHealthcare SectorNASDAQ Exchange
Market Cap$449.08M$12.12B$7.18B$12.88B
Dividend YieldN/A2.62%2.54%11.27%
P/E Ratio-2.22787.65273.1725.44
Price / Sales1.79760.49637.42103.51
Price / CashN/A15.3228.7436.03
Price / Book0.8810.4911.086.36
Net Income-$190.29M$2.83B$3.48B$349.79M
7 Day Performance-4.81%0.26%0.21%-0.48%
1 Month Performance8.96%5.45%7.75%4.17%
1 Year Performance-44.47%6.15%24.68%15.11%

Canopy Growth Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CGC
Canopy Growth
0.9395 of 5 stars
$0.99
-1.1%
N/A-44.5%$445.26M$251.01MN/A1,128
ACB
Aurora Cannabis
1.9275 of 5 stars
$3.60
-2.2%
N/A-26.0%$238.62M$247.82MN/A1,028
CRON
Cronos Group
1.9301 of 5 stars
$3.15
+0.3%
$2.30
-27.0%
+30.0%$1.16B$146.59M15.75450
OGI
Organigram Global
2.5591 of 5 stars
$1.23
-0.4%
N/A-29.8%$173.40M$185.07M2.661,139
SNDL
SNDL
3.4316 of 5 stars
$1.23
-2.4%
$5.00
+306.5%
-49.4%$324.32M$677.32MN/A2,751

Related Companies and Tools


This page (NASDAQ:CGC) was last updated on 8/31/2026 by MarketBeat.com Staff.
From Our Partners